key: cord-0971494-f4mg63f1
authors: Plonski, Noel-Marie; Meindl, Richard; Piontkivska, Helen
title: Differential ADAR editing landscapes in major depressive disorder and suicide
date: 2021-05-23
journal: bioRxiv
DOI: 10.1101/2021.05.22.445267
sha: e4152efc88fedad4c255e13b0892e73afe666ea0
doc_id: 971494
cord_uid: f4mg63f1

Neuropsychiatric disorders, including depression and suicide, are becoming an increasing public health concern. Rising rates of both depression and suicide, exacerbated by the current COVID19 pandemic, have only hastened our need for objective and reliable diagnostic biomarkers. These can aide clinicians treating depressive disorders in both diagnosing and developing treatment plans. While differential gene expression analysis has highlighted the serotonin signaling cascade among other critical neurotransmitter pathways to underly the pathology of depression and suicide, the biological mechanisms remain elusive. Here we propose a novel approach to better understand molecular underpinnings of neuropsychiatric disorders by examining patterns of differential RNA editing by adenosine deaminases acting on RNA (ADARs). We take advantage of publicly available RNA-seq datasets to map ADAR editing landscapes in a global gene-centric view. We use a unique combination of Guttman scaling and random forest classification modeling to create, describe and compare ADAR editing profiles focusing on both spatial and biological sex differences. We use a subset of experimentally confirmed ADAR editing sites located in known protein coding regions, the excitome, to map ADAR editing profiles in Major Depressive Disorder (MDD) and suicide. Using Guttman scaling, we were able to describe significant changes in editing profiles across brain regions in males and females with respect to cause of death (COD) and MDD diagnosis. The spatial distribution of editing sites may provide insight into biological mechanisms under-pinning clinical symptoms associated with MDD and suicidal behavior. Additionally, we use random forest modeling including these differential profiles among other markers of global editing patterns in order to highlight potential biomarkers that offer insights into molecular changes underlying synaptic plasticity. Together, these models identify potential prognostic, diagnostic and therapeutic biomarkers for MDD diagnosis and/or suicide.

generated "stacks". The stack depths are recorded for each excitome site. If the stack depth is greater 193 than 10 reads, A to G (or T to C) editing frequency is determined by dividing number of Gs (or Cs) 194 found by the total number of nucleotides found at the specific position; stacks with less than 10 reads 195 are filtered out (Supplemental Table 4 ). Guttman Scaling matrices are created by assigning each site a 196 value of 1 if editing frequency is above 0%, or 0 if editing frequency is at 0%. We also filtered out sites 197 detected only in one of the samples as potential noise. We considered the higher cut-off of at least 5% 198 editing frequencies inferred from each stack to reduce the chance of erroneous designation of an editing 199 event (Sharma et al., 2019) ; however, the resultant lists of differentially edited genes/sites were 200 essentially similar for each cut-off of using no cutoff (0%), 1%, or the more stringent 5%. Percent of 201

Guttman scale rank order editing site category change between 0% and 1%, 0% and 5% and 1% to 5% 202 cut-off values show highly similar results among editing sites (Supplemental Table 5 & Supplemental 203 Figure 1 ), especially those found to be potential biomarkers (Supplemental Table 6 and Supplemental 204 Figure 2 ). Thus, we will focus on results based on no cut-off threshold as to not miss editing sites with 205 normally low editing frequency. 206 207

Guttman Scaling is applied to rank and order the excitome ADAR editing sites based on 209 presence of editing events while computing a score for each sample (Guttman, 1944; Proctor, 1970; 210 Simmons et al., 2010) . Custom R scripts are used with "sirt" R package to calculate probabilistic 211 Guttman Scale model. The samples are scored based on the hierarchal ranks and a three-way ANOVA 212 included in R-base is used to determine statistical differences based on scores between the cause of 213 death and MDD diagnosis. The rank order of editing sites is used to create topological editing profiles 214 that can then be compared between conditions to see variation in editing landscapes. Rank groups can 215 be additionally grouped into three categories within each condition. Specifically, the first rank group 216 category consists of sites that are completely edited in all samples. Category two includes sites that 217 have both edited and unedited samples. The last rank group category contains no editing in any sample. 218

These assigned Guttman categories are compared within brain region and sex between COD and MDD 219 diagnosis using the "UpSetR" package to create upset plots to explore editing site variation among 220 regions and sexes (Conway et al., 2017; Lex et al., 2014) . 221 222

To identify potential biomarkers of MDD or suicide, we applied random forest classification 224 modeling using "randomForest" R package which implements Breiman's random forest algorithm 225 (Liaw & Wiener, 2002) enabling us to integrate the editing markers with other transcriptomics and 226 clinically relevant indicators (Supplemental Figure 3 ). The measurements found to have significant 227 differences -including the Guttman scale maximum likelihood estimates of scores, excitome editing 228 frequencies, snpEff predicted with high and moderate impact on protein structure or function, counts of 229 editing in exon regions, previous MDD diagnosis, biological sex, and brain regions -were used as 230 variable parameters in random forest modeling. The novel approach of quantifying Guttman scaling 231 and then using a non-parametric alternative, which utilizes bootstrap consensus of random 232 classification decision trees (random forest), enables us to predict clinically relevant biomarkers using 233

Variance Importance (VIMP) and Minimal Depth (Ishwaran & Kogalur, 2010) The original analyses conducted on the RNA-seq data sets (Pantazatos et al., 2017; Labonté et 238 al., 2017) focused on differential gene and exon expression, rather than ADAR editing, in MDD and 239

suicide. Both studies identified differential expression of genes involved in neural pathways (such as 240 oligodendrocyte differentiation, regulation of glutamatergic neurotransmissions and oxytocin receptor 241 expression, DNA-dependent ATPase) and immune-related genes linked with altered microglia and/or 242 astrocyte activity, resulting in changes to synaptic plasticity and neuroprotection. Although variant 243 calling was performed in one study (Pantazatos et al., 2017) , its focus was on identifying genomic 244 single nucleotide polymorphisms and indels as opposed to our approach of investigating RNA editing 245 landscapes. The second study (Labonté et al., 2017) compared differential gene expression between 246 biological sexes across brain regions and did not examine variants. Based on their findings of 247 significant sex differences, here we treat male and female samples separately to compare differential 248 editing patterns between sexes. 249

We compared global ADAR editing landscapes across COD, and MDD diagnosis, by gender 250 and brain region. There were no significant changes to global ADAR editing profiles between COD, 251 brain regions, or MDD , but there were statistically significance differences when compared by gender 252 with a small effect size (Cohen's d = 0.202846813). However, there were relatively small sample sizes 253 across categories, with some having rather large variances. Quality control measures ph was also 254 significant with rin and pmi approaching significance, therefore they were included in the model (Table  255 1). When further exploring the differential trends in global editing patterns between sexes, there are trends in global editing patterns such as females show more ADAR editing with suicide as the COD in 257 the dlPFC including BA9, aINS, and Cg25 ( Figure 1A ), whereas males show decreased editing in these 258 regions ( Figure 1B ). Additionally, females showed decreased editing in OFC, NAcc, and sub and males 259 also had decreased editing in the sub but had increased editing in OFC, no change in editing in the 260

NAcc. Females also have increased editing in the OFC with MDD diagnosis but not with suicide as the 261 COD (Supplemental Figure 4A ). The majority of these editing sites, over 75%, are located in introns in 262 all brain regions, males and females with no significant differences between COD or MDD diagnosis 263 (Supplemental Table 7 & Supplemental Figure 5 ). Up and down stream regions have over 10% and 8% 264 respectively with less than 2% located in exons. MDD diagnosis and COD in males shows increased 265 editing in the OFC but PFCBA9 along with the other brain regions shows decreased editing 266 (Supplemental Figure 4B ). Females like males have decreased editing in PFCBA9, the NAcc, and aINS 267 unlike with females who commit suicide who have increased in editing in PFCBA9 and aINS. Females 268 have decreased editing in Sub in those that commit suicide, while males showed increased editing. 269

Females have increased editing in the PFC and Cg25 with MDD diagnosis while males have decreased 270 editing in these regions. Changes to editing patterns in these specific regions can potentially explain the 271 broad spectrum of symptoms seen in depression and suicidal behavior. Moreover, the differences 272 between editing profiles in biological sexes can contribute to differences in manifested symptoms. 273

While these findings offer an initial glimpse into potentially distinct editing patterns associated with 274 different diagnoses, further extensive validation is needed to link specific editing events to clinical 275 and/or behavioral symptoms. 276

Ward's test using the number of predicted high or moderate impact editing sites in individual 277 genes was done using DESeq2 differential expression approach, identifying 660 genes with increased 278 number of ADAR editing sites (Supplemental Table 8 ). These moderate/high impact editing sites 279 included non-synonymous amino acid changes, and editing in 5' or 3' prime untranslated regions with 280 anticipated effects on translational activity. The top 5 genes included SSH2 (slingshot protein 281 phosphatase 2) involved in axonal guidance, TRIM44 (tripartite motif containing 44) important in 282 differentiation and maturation of neural cells, GMR7 (glutamate metaboltrophic receptor 7) involved in 283 excitatory signaling, NRCAM (neuronal cell adhesion molecule) responsible for axonal cone growth, 284 and TJP1 (tight junction protein 1) ( Figure 3A ). These and other differentially edited genes were 285 identified as part of the following gene ontology pathways: cell junction assembly, organelle assembly, 286 mitotic cell cycle, metabolic process ( Figure 3B ). Pathway enrichment showed three-fold increase in 287 genes involved in cell junction assembly, a two-fold increase in genes involved in organelle assembly, 288 and a one-fold increase in those involved in miotic cell cycle, and metabolic process ( Figure 3C ). 289

Changes to these pathways can affect the neural cells communication with other cells by changing 290 ability to package neurotransmitters and form junctions with other nearby cells, thereby leading to 291 changes in synaptic plasticity. 292

Mapping ADAR editing landscapes with Guttman Scale 294

Because of its relevance to synaptic plasticity, the excitome editing needs to be considered as a 295 separate subset of global editing sites for us to better understand plasticity changes seen in depressive 296 disorders. Guttman scaling maximum likelihood scores using the excitome editing sites were 297 significantly different in COD and tissue with MDD diagnosis approaching significance and no 298 significant difference between genders (Table 2) . COD had a strong effect size and tissue had 7 299 statistically significant tissue pairs among the 21 pairs tested, with two of the comparisons having 300 moderate effect size and four of the comparisons having high effect size showing significantly large 301 differences with respect to Guttman Scale scoring (Table 3 ). Looking at the excitome compared to 302 global ADAR editing patterns females had higher scores indicating increased ADAR editing in all brain 303 regions in suicide except in NAcc ( Figure 4A ). Males had increased editing in PFC including BA9, 304

NAcc, and sub and decreased scores in OFC, aINS, and Cg25 in suicide ( Figure 4B ). Females 305 diagnosed with MDD had similar patterns to females who committed suicide except in the PFC and sub 306

where there are lower scores or less editing, and increased scores in the NAcc (Supplemental Figure  307 6A). Males diagnosed with MDD have similar increases as seen in females diagnosed with MDD but 308 different patterns than those seen in males with suicide (Supplemental Figure 6B ). There were increases 309 in scores in all regions except PFCBA9 in males and females diagnosed with MDD. Additionally, 310 females show decreases in editing in the PFCBA8. 311

To further explore differences in editing landscapes, we looked at the number of changes to 312 editing patterns reflected by Guttman hierarchical rank order, where the smaller magnitude of change 313 indicates higher homogeneity/similarity across phenotypes. Regardless of brain region or sex, 7 editing 314 sites did not change their rank positions, indicating that these sites likely do not play a role in COD. 315

There were 22 sites that decreased no more than 5 ranks from natural cause of death to suicide, and 15 316 sites that increased no more than 5 ranks, respectively ( Figure 5A ), likely indicating that these are 317 relatively minor players, if any, in suicide. On the other hand, two-thirds of the editing sites were more 318 than 5 ranks away from where they were positioned in natural COD, signifying major heterogeneity 319 across samples with the same phenotype, making them good candidates for follow-up differential 320 diagnostic studies. Similarly, there were 25 sites that decreased no more than 5 ranks from control to 321 MDD diagnosis and 39 sites that increased no more than 5 ranks (Supplemental Figure 7A ), unlikely to be major players. On the other hand, three-fourths of the editing sties were more than 5 ranks away 323 from control samples compared to those with MDD diagnosis, indicating these editing sites may 324 contribute to molecular mechanisms behind symptoms of depression. Overall, when differences 325 between brain regions and sexes within suicide and MDD diagnosis are considered, both disordered 326 phenotypes have a broader and higher variation in ranking of editing sites than that of those with 327 natural causes of death, or age matched controls without a MDD diagnosis ( Figure 5B & Supplemental 328 Figure 7B ). This observed editing diversity may be contributing to the broad spectrum of manifested 329 symptoms seen in depression and suicidal behavior. 330

To further explore changes to hierarchical rank order we assigned categories based on editing 331 status allowing us to focus on overall changes seen in suicide between brain regions and sex. The Sub 332 region in females has almost double the amount of editing changes than any other region, 80 sites, with 333 11 of those being unique to the region ( under the curve (AUC) of 91.7, and the COD test set model had 91% accuracy with AUC 97.9 (Table  351 4). The MDD training model had an accuracy of 72% with AUC of 79.7, and the test set model was 352 75% accurate at predicting MDD diagnosis with AUC 82.5 (Table 4 ). These models were then used to 353 predict potential clinically relevant biomarkers for diagnosis, prognosis, appropriate treatments and 354 potential targets for drug therapy development by finding the variables most important to the COD or 355

Random forest modeling predicted top scoring biomarkers found in common between both 357 VIMP/minimal depth (Supplemental Figure 9 ) and partial dependence analysis (Supplemental Figure  358 10) can be used to provide insight into the molecular mechanisms underlying suicidal behavior (Table  359 6). Further, we examined differential editing frequencies of the top biomarkers. Of these top 360 biomarkers, IGFBP7(position 95, here and later) had no significant difference between COD, MDD 361 diagnosis, gender or brain region but there was a significant difference for COD when brain region 362 were also considered looked at with a strong strength of correlation in 11 out of 21 comparisons 363 between tissues (F=5.411, p=0.000104, Table 6 ). NOVA1(387) showed no significant difference 364 between COD, MDD diagnosis, or brain region but approached significance between genders 365 (F=2.749, p=0.0987). PCP4(42) was signification different in COD (F=8.797, p=0.003338, Cohen's d = 366 0.149405) and brain region (F=1.966, p=0.000192) but not MDD diagnosis or gender. VWF (789) is 367 statistically significant with extremely high strength of association between tissues (F=1.940, 368 p=0.000237, Table 6 ) but not COD, gender or MDD diagnosis. VWF(484) also was statistically 369 significant between tissues with 5 out of 21 comparisons have strong strength of correlation 370 (F=1.425,p=0.0338, Table 6 ) but not between COD, MDD diagnosis, or gender. Another editing site 371 VWF(789), was significantly different for tissues with a moderate strength of association for 5 out of 372 the 21 tissue comparisons, but not for COD, MDD diagnosis or biological sex (Table 6 ).This further 373 supports the identification of some of these as potential biomarkers for both suicide risk and 374 depression. Overall, editing site frequencies in males had less editing in suicide compared to controls, 375 whereas females have more editing in most brain regions. In addition to editing site frequencies, 376 variables such as transcript-level high impact on protein structure and function, brain region, maximum 377 likelihood scores from Guttman scale, and global ADAR editing counts were also in the top 30 378 variables for both the COD and MDD random forest models. Notably, variables such as the number of 379 ADAR editing sites found in the exon region of the transcript, gene-level high impact counts and 380 transcript-level moderate impact counts were part of the top 30 for the MDD, but not COD diagnosis 381 model, indicating editing sites in the protein coding regions are more likely to be underlying behavioral 382 symptoms seen in depressive disorders but not the pathology of suicide. 383 384 Discussion 385

Studies have found differences in gene expression during different stages of MDD as well as 386 remission when on drug therapy (Hepgul et al., 2013; Mamdani et al., 2011) . In addition, studies have also found differential gene expression in suicide attempts (Flory et al., 2017) and in completed 388 suicides (Cabrera et al., 2019) . Our findings of differential editing in these regions offer novel insights 389 into patterns of differential gene regulation and function that can be driving synaptic plasticity across 390 multiple pathways in the brain. Differential editing landscapes in any of the regions studied here can 391 potentially explain molecular mechanisms behind diverse clinical behaviors and symptoms. In addition 392 to focusing on global editing pattern, our unique approach of using Guttman scaling combined with 393 random forest modeling allows for us to highlight biomarkers from the top scoring editing sites. These 394 editing biomarkers give insight into potential mechanistic links to the fine-tuning of synaptic plasticity 395 and neuropsychiatric disorders. 396

In particular, our results identified significant differences in editing profiles across different 397 brain regions, where each brain region examined (aINS, OFC, dlPFC, Cg25, aINS, NAcc, Sub, 398 dlPFC9) exhibited distinct editing profiles between controls and COD or MDD diagnosis. These 399 regions have been linked to a variety of neurological and psychiatric disorders, symptoms and 400 manifestations. Editing changes in target genes in the aINS is part of many pathways in the brain and 401 contribute to the molecular underpinnings of symptoms of depression and suicidal behavior including 402 changes to emotional homeostasis and risk assessment (Beauchaine et al., 2019; Soloff et al., 2012; 403 Gogolla, 2017) . Differential editing profiles in the OFC can alter neurotransmitters in emotion and 404 reward pathways (Kolb et al., 2003) . Structural abnormalities (W. Peng et al., 2019) , and connectivity 405 disturbances (Rolls et al., 2020) have been noted in the OFC depression and anxiety. Editing events 406 changing protein structure or function can contribute the morphological and molecular dysfunctions 407 seen in this region. Working memory, cognitive flexibility and planning are part of the function of the 408 PFC (Duncan, 2001; Miller & Cohen, 2001) and disturbances here are implicated in depression 409 (Drevets et al., 1998) , therefore differential editing profiles can help explain on a molecular level 410 changes resulting in suicidal behaviors. Changes in blood flow and metabolic function in the Cg25 411 been implicated in depression (Ebert & Bemeier, 1996) , and we have identified editing targets present 412 in depression and suicide that are linked with those functions. Behaviorally, differential edits at these 413 regions can result in changes in mood and self-esteem (Vogt, 2005) . Deep brain stimulation in the Nac 414 can help with treatment resistant depression (Bewernick et al., 2010) , as interneurons neurons located 415 here help regulate depression (Warner-Schmidt et al., 2012) . Calcium channels like the ones we 416 identified as differentially edited in depression and suicide may control depressive like behaviors 417 (Goffer et al., 2013) . 418

Cell junction assembly and organization were two pathways that were overrepresented over 419 two-fold. Cell junction formation and control is important for neuronal cell synaptic formation behind 420 neural plasticity. Increases to ADAR editing in the genes involved in this pathway can alter the 421 neuron's ability to form new synaptic functions or remodel existing synapses causing changes to 422 synaptic plasticity in suicidal behavior (Goda & Davis, 2003; Li & Sheng, 2003) . Microtubule process 423 and organization is important for neural development (Lasser et al., 2018) , and neuron structure and 424 function in the dopaminergic function especially in depression (Yang et al., 2018) . Cell component 425 assembly, biogenesis, and organization and organelle formation all play a role in neurotransmitter 426 transport and release, and we have shown significant increases in the amount of editing found in genes 427 in these pathways in both suicide and depression. Organelles are needed for proper packaging, 428 trafficking, holding and tracking of neurotransmitters for cell signaling that drives post synaptic 429 plasticity (Kennedy & Ehlers, 2006) . Metabolic function pathways are also overrepresented with higher 430 frequency of editing in genes in these pathways. Metabolic function is important in not only normal 431 housekeeping functions of cells, but also providing energy for cellular processes involved in signaling 432 and synaptic plasticity. The importance and variety of these pathways may be behind the wide range of 433 behavior and somatic symptoms seen in suicidal behavior. 434 Furthermore, the top potential biomarkers predicted in our study offer insight into the specific 435 molecular mechanisms under-pinning MDD and suicidal behavior. Changes to editing in SRP9 affect 436 protein localization (Ivanova et al., 2015) , which in turn can affect not only the cells' ability to function 437 at a normal level, but also package and deliver neurotransmitters for synaptic plasticity. Furthermore, 438 differential editing can affect proteolytic degradation, angiogenesis and induce apoptosis by altering 439 spatiotemporally regulated variant isoform of IGBPF7 another potential biomarker (Godfried Sie et al., 440 2012) . Editing in FLNA which interferes with many proteins can change cell motility and signaling 441 ability by affecting the neurons' ability to form the proper microskeleton used for stability, transport, 442 nuclear division and forming connections to other cells this can result in the ability to control blood 443 pressure (Jain et al., 2018) and for proper neurodevelopment (Eran et al., 2013) . The two differential 444 editing sites we found in VWF can affect the link between the endothelium of blood vessels and 445 platelets (Randi et al., 2018) . Stress and inflammation have been shown to change VWF binding 446 altering the permeability of the blood brain barrier which can continue the cycle of inflammation and 447 further damage brain tissues and pathways (Noubade et al., 2008; Ryu & McLarnon, 2009; Suidan et 448 al., 2013; Zhang et al., 2002) . Furthermore, differential editing in the following biomarkers can alter 449 splicing profiles (NOVA1) (Irimia et al., 2012) , the ability to repair DNA after oxidative stress (NEIL1) 450 (Yeo et al., 2010) , and cell differentiation and neurotransmitter release controlling synaptic plasticity 451 (PCP4) (Wei et al., 2011) . Differential editing plays a role in inhibitory signaling by editing GABRA3 452 at high levels in the adult brain. We found decreased editing in the PFC in both males and females, which can result in slower response to the GABA inhibitory neurotransmitter, thereby causing the cells 454 to become more easily excitable (Rula et al., 2008) . Excitatory signaling through kainate glutamate 455 receptor GRIK2 can affect ion channel mediated signaling by differential editing seen in bipolar 456 disorders and has been found dysregulated in neuro psychiatric disorders (Silberberg et al., 2012) . 457

Although we found significant difference in editing landscapes, future functional studies should 458 explore, analyze and test the involvement of individual editing sites associated with symptoms of 459 depression and suicide. 460

In the future, single cell-based transcriptome analysis can be used to identify nuances of 461 differential ADAR editing landscapes, including between neural cell types within smaller brain regions 462 and individual neural circuits. However, currently the accuracy of computational approaches of variant 463 calling relies on a read depth greater than 15 (Ouyang et al., 2018) and most single cell datasets are 464 currently performed using 10X genomics which is mostly below the threshold for accuracy. Since the 465 majority of single cell RNA-seq experiments usually have read depths of no more than 10, they may 466 not be as accurate in determining ADAR editing events. Furthermore, our approach to elucidating 467 nuanced differential editing patterns and identifying relevant biomarkers can be extended to other 468 conditions beyond neuropsychiatric disorders, particularly in the context of immune response, although 469 further research is needed to directly connect clinical symptoms and observed phenotypic differences to 470 the subtle changes in spatiotemporal editing landscapes. 471

We would like to note that although some of the samples had lower read depth, thereby 472 potentially limiting our power to identify editing events, we were still able to identify differential 473 patterns while controlling for false positives. We accomplished this by applying quality control 474 measures for Guttman scaling, such as only including sites that were present in at least two samples 475 within a condition and with a stack depth of 10 or larger. While we may have omitted some events with 476 low editing frequencies, the reduction in the number of potential false positive events outweighs the 477 impact of missing the few low-frequency editing sites. Our proposed statistic modeling approach that 478 combines Guttman scaling with random forest modeling enables us to glean valuable insights even 479 from relatively small samples sizes such as was used here however, we would like to advocate for the 480 need of further studies with larger sample sizes to model more precise prediction of suicide. Moreover, 481 since these editing profiles show differences between brain regions, there underscores the need for a 482 less invasive way of measuring editing profiles such as through blood or saliva tests. In the future, to 483 find clinically relevant biomarkers for diagnosis, prognosis or even therapy, editing profiles would need 484 to be confirmed in blood and other bodily fluids. 485

Our novel statistical model of quantifying Guttman scaling rank order and maximum likelihood 488 scores with random forest modeling provides a way to take advantage of high-depth sequencing 489 datasets, whether already available or newly obtained, to identify clinically relevant biomarkers. These 490 biomarkers can provide insight into molecular mechanisms in differential brain regions underlying 491 MDD and suicide. Additionally, these diagnostic, prognostic and therapeutic biomarkers once 492 confirmed can be used in conjunction with current psychological assessments to determine risk for 493 MDD and suicidal behavior. Here we leverage two previously published RNA-seq data sets to delineate 494 ADAR editing landscapes and use these differential editing profiles for prediction of potential 495 biomarkers for suicide and depression. shown in red, and no change shown in yellow. Reference anatomy features shown in blue helps in the 522 location of brain regions and are involved in pathways within studied regions. Similar editing 523 landscapes are observed between females and males who commit suicide, with differences seen in 524

Cg25 and OFC regions. Males who commit suicide show a different ADAR editing pattern than those 525 of any of the other categories. Similarly to the global differential ADAR editing patterns, Guttman 526 scale MLE scores vary between brain regions in females and males in suicide, as well as between 527 suicide and natural causes of death (shown in blue and red in violin plots, respectively). The connected dots shown in red represent the same region where both sexes share the same editing 546 sites. For example, the first dots in red represent 1 editing in common between females and males in 547 Nac which has 40 changes to editing sites in both males and females. The second red dots represent 1 548 editing site in common between females and males in the PFCB9. Larger number of dots under the bar 549 indicate higher number of regions that share changes in that editing site. 550 Test set error rate 0.28,0.48,0.12 0.25,0.3,0.2 0.14,0.33,0.08 0.08,0.14,0.06 567 

Self-injuring adolescent girls exhibit insular cortex volumetric abnormalities that are similar to those seen in adults with borderline personality disorder

Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression

Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118

UpSetR: An R package for the visualization of intersecting sets and their properties

Increased serotonin 2C receptor mRNA editing: A possible risk factor for suicide

Neuroimaging abnormalities in the subgenual prefrontal cortex: Implications for the pathophysiology of familial mood disorders

An adaptive coding model of neural function in prefrontal cortex

Mechanisms of Synapse Assembly and Disassembly

IGFBP7's susceptibility to proteolysis is altered by A-to-I RNA editing of its transcript

Calcium-Permeable AMPA Receptors in the Nucleus Accumbens Regulate Depression-Like Behaviors in the Chronic Neuropathic Pain State

The insular cortex

A Basis for Scaling Qualitative Data

Depression pathogenesis and treatment: What can we learn from blood mRNA expression?

Editing of Neurotransmitter Receptor and Ion Channel RNAs in the Nervous System

Evolutionarily conserved A-to-I editing increases protein stability of the alternative splicing factor Nova1

Consistency of Random Survival Forests

Alu RNA regulates the cellular pool of active ribosomes by targeted delivery of SRP9/14 to 40S subunits

RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure

RNAEditor: Easy detection of RNA editing events and the introduction of editing islands

Joint effect of ADARB1 gene

gene and stressful life events on suicide attempt risk in patients with major psychiatric disorders

Organelles and Trafficking Machinery for Postsynaptic Plasticity

Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease

Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

Brain Plasticity and Behavior

Sex-Specific Transcriptional Signatures in Human Depression

The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders

UpSet: Visualization of Intersecting Sets

Some assembly required: The development of neuronal synapses

Classification and Regression by randomForest

Serotonin 2c receptor RNA editing in major depression and suicide

Gene expression biomarkers of response to citalopram treatment in major depressive disorder

Model selection and multimodel inference using the AICcmodavg package

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

An Integrative Theory of Prefrontal Cortex Function

A unique gene expression signature associated with serotonin 2C receptor

Von-Willebrand Factor Influences Blood Brain Barrier Permeability and Brain Inflammation in Experimental Allergic Encephalomyelitis

Accurate identification of RNA editing sites from primitive sequence with deep neural networks

Wholetranscriptome brain expression and exon-usage profiling in major depression and suicide: Evidence for altered glial, endothelial and ATPase activity

Brain structural abnormalities in emotional regulation and sensory processing regions associated with anxious depression

Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome

StringTie enables improved reconstruction of a transcriptome from RNA-seq reads

Automated Isoform Diversity Detector (AIDD): a pipeline for investigating transcriptome diversity of RNA-seq data

A probabilistic formulation and statistical analysis of Guttman scaling

Accurate identification of human Alu and non-Alu RNA editing sites

Von Willebrand factor regulation of blood vessel formation

Functional connectivity of the right inferior frontal gyrus and orbitofrontal cortex in depression

A-to-I RNA Editing: Effects on Proteins Key to Neural Excitability

Developmental Modulation of GABAA Receptor Function by RNA Editing

A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain

RNA editing blood biomarkers for predicting mood alterations in HCV patients

Serotonin 2C Receptors: Suicide, Serotonin, and Runaway RNA Editing

Regulation of Serotonin 2C Receptor Pre-mRNA Editing by Serotonin

dbSNP: The NCBI database of genetic variation

Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders

Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims: NeuroReport

Structural brain abnormalities and suicidal behavior in borderline personality disorder

Spatio-temporal profiling of Filamin A RNA-editing reveals ADAR preferences and high editing levels outside neuronal tissues

Endothelial Von Willebrand Factor Promotes Blood-Brain Barrier Flexibility and Provides Protection From Hypoxia and Seizures in Mice

Pain and emotion interactions in subregions of the cingulate gyrus

Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior

Impaired Locomotor Learning and Altered Cerebellar Synaptic Plasticity in pep-19/pcp4-Null Mice

Depression and other common mental disorders: global health estimates

Stably maintained microtubules protect dopamine neurons and alleviate depression-like behavior after intracerebral hemorrhage

RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1

Correlation of VEGF and Angiopoietin Expression with Disruption of Blood-Brain Barrier and Angiogenesis after Focal Cerebral Ischemia

Quantitative Analysis of Focused A-To-I RNA Editing Sites by Ultra-High-Throughput Sequencing in Psychiatric Disorders